Improving cervical cancer detection and treatment in Mexico City clinics
Interventions to increase adherence to cervical cancer early detection and treatment recommendations in Mexico City clinics
This study is looking to find out what helps or hinders women and doctors in Tlalpan, Mexico City, from following the guidelines for early detection and treatment of cervical cancer, so they can come up with better ways to make sure more women get screened and treated, ultimately helping to save lives.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10528196 on NIH RePORTER |
What this research studies
This research aims to enhance adherence to cervical cancer early detection and treatment guidelines in clinics located in Tlalpan, Mexico City. It will identify barriers and facilitators that affect how well patients and healthcare providers follow these guidelines, which have been in place since 1974. By understanding these factors, the research will develop targeted strategies to improve screening and follow-up care for cervical cancer, ultimately aiming to reduce mortality rates among Mexican women.
Who could benefit from this research
Good fit: Ideal candidates for this research are women in Mexico City who are eligible for cervical cancer screening and treatment according to the Mexican guidelines.
Not a fit: Patients outside of Mexico City or those who do not meet the eligibility criteria for cervical cancer screening may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased cervical cancer screening and treatment adherence, significantly reducing mortality rates among women in Mexico.
How similar studies have performed: Previous research has shown success in improving adherence to cancer screening guidelines in other regions, suggesting that similar approaches may be effective in Mexico.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Spiegelman, Donna L — Yale University
- Study coordinator: Spiegelman, Donna L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.